Growth Equity Opportunities IV, LLC Insider Trading $CASC Cascadian Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Growth Equity Opportunities IV, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Growth Equity Opportunities IV, LLC. Growth Equity Opportunities IV, LLC is 10% Owner in ARCA biopharma, Inc. ($ABIO) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and 10% Owner in Cascadian Therapeutics, Inc. ($CASC).
Growth Equity Opportunities IV, LLC in Cascadian Therapeutics, Inc.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Growth Equity Opportunities IV, LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Mar 13 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Growth Equity Opportunities IV, LLC in Cascadian Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, ABIO, AVEO, CASC
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13 2018 | CASC | Cascadian Therapeu ... | Growth Equity Opportunities IV ... | 10% Owner | Sell | U | 0.00 | 10,882,574 | 0 | 0 | 10.9 M to 0 (-100.00 %) |
| Feb 22 2018 | CASC | Cascadian Therapeu ... | Growth Equity Opportunities IV ... | 10% Owner | Option Exercise | C | 3.30 | 1,818,000 | 5,999,400 | 0 | |
| Feb 22 2018 | CASC | Cascadian Therapeu ... | Growth Equity Opportunities IV ... | 10% Owner | Buy | C | 3.30 | 1,818,000 | 5,999,400 | 10,882,574 | 9.1 M to 10.9 M (+20.06 %) |
| Feb 22 2018 | CASC | Cascadian Therapeu ... | Growth Equity Opportunities IV ... | 10% Owner | Option Exercise | C | 3.30 | 1,818,000 | 5,999,400 | 0 | |
| Feb 22 2018 | CASC | Cascadian Therapeu ... | Growth Equity Opportunities IV ... | 10% Owner | Buy | C | 3.30 | 1,818,000 | 5,999,400 | 10,882,574 | 9.1 M to 10.9 M (+20.06 %) |
Page: 1